Caption Management’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Hold |
0
| – | – | – | 930 |
|
2025
Q1 | – | Hold |
0
| – | – | – | 993 |
|
2024
Q3 | – | Hold |
0
| – | – | – | 796 |
|
2024
Q2 | – | Hold |
0
| – | – | – | 752 |
|
2024
Q1 | – | Sell |
-1,682
| Closed | -$30.2K | – | 835 |
|
2023
Q4 | $30.2K | Buy |
+1,682
| New | +$30.2K | ﹤0.01% | 394 |
|
2023
Q2 | – | Sell |
-5,804
| Closed | -$110K | – | 695 |
|
2023
Q1 | $110K | Hold |
5,804
| – | – | ﹤0.01% | 273 |
|
2022
Q4 | $132K | Buy |
+5,804
| New | +$132K | ﹤0.01% | 325 |
|
2022
Q3 | – | Sell |
-8,700
| Closed | -$215K | – | 826 |
|
2022
Q2 | $215K | Buy |
+8,700
| New | +$215K | ﹤0.01% | 351 |
|
2022
Q1 | – | Hold |
0
| – | – | – | 903 |
|
2021
Q4 | – | Sell |
-5,000
| Closed | -$210K | – | 887 |
|
2021
Q3 | $210K | Buy |
+5,000
| New | +$210K | ﹤0.01% | 427 |
|
2021
Q2 | – | Sell |
-16
| Closed | -$1K | – | 745 |
|
2021
Q1 | $1K | Buy |
+16
| New | +$1K | ﹤0.01% | 349 |
|
2020
Q4 | – | Sell |
-10,500
| Closed | -$289K | – | 588 |
|
2020
Q3 | $289K | Buy |
+10,500
| New | +$289K | 0.01% | 240 |
|